DNER and neoplasm: When it was tested using patient-derived tumor organoid formation assays, the BET bromodomain inhibitor hexamethylene bisacetamide (HMBA) [29], which robustly induced endoderm commitment in hPSCs, selectively suppressed tumor initiation in colorectal tumor tissues.